UBS Group’s Predictive Oncology POAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,977
Closed -$28.8K 9255
2025
Q1
$28.8K Buy
+18,977
New +$28.8K ﹤0.01% 6676
2024
Q4
Sell
-4,908
Closed -$3.87K 8953
2024
Q3
$3.87K Sell
4,908
-30,656
-86% -$24.2K ﹤0.01% 6997
2024
Q2
$37K Buy
35,564
+34,301
+2,716% +$35.7K ﹤0.01% 5772
2024
Q1
$3.22K Sell
1,263
-1,296
-51% -$3.31K ﹤0.01% 6590
2023
Q4
$8.42K Buy
2,559
+90
+4% +$296 ﹤0.01% 6349
2023
Q3
$7.9K Sell
2,469
-1,439
-37% -$4.61K ﹤0.01% 6067
2023
Q2
$19K Buy
3,908
+2,712
+227% +$13.2K ﹤0.01% 5828
2023
Q1
$7.82K Buy
1,196
+1,105
+1,214% +$7.23K ﹤0.01% 6680
2022
Q4
$565 Sell
91
-711
-89% -$4.41K ﹤0.01% 8933
2022
Q3
$6K Buy
802
+774
+2,764% +$5.79K ﹤0.01% 7944
2022
Q2
$0 Buy
+28
New ﹤0.01% 9603
2022
Q1
Sell
-1,833
Closed -$35K 9502
2021
Q4
$35K Buy
1,833
+894
+95% +$17.1K ﹤0.01% 6125
2021
Q3
$25K Buy
939
+755
+410% +$20.1K ﹤0.01% 5795
2021
Q2
$5K Buy
+184
New +$5K ﹤0.01% 7454
2021
Q1
Sell
-1,869
Closed -$27K 8149
2020
Q4
$27K Buy
1,869
+1,733
+1,274% +$25K ﹤0.01% 5715
2020
Q3
$2K Sell
136
-72
-35% -$1.06K ﹤0.01% 6794
2020
Q2
$7K Sell
208
-92
-31% -$3.1K ﹤0.01% 6371
2020
Q1
$9K Buy
300
+199
+197% +$5.97K ﹤0.01% 6090
2019
Q4
$5K Buy
+101
New +$5K ﹤0.01% 6511
2019
Q1
Hold
0
7045
2018
Q4
Hold
0
7181
2018
Q1
Sell
-40
Closed -$8K 7017
2017
Q4
$8K Buy
40
+15
+60% +$3K ﹤0.01% 6190
2017
Q3
$7K Sell
25
-3
-11% -$840 ﹤0.01% 6162
2017
Q2
$8K Buy
+28
New +$8K ﹤0.01% 5970
2017
Q1
Sell
-13
Closed -$7K 6778
2016
Q4
$7K Buy
13
+8
+160% +$4.31K ﹤0.01% 6121
2016
Q3
$4K Buy
+5
New +$4K ﹤0.01% 6270
2016
Q2
Sell
-2
Closed -$2K 6887
2016
Q1
$2K Buy
+2
New +$2K ﹤0.01% 6436
2015
Q4
Hold
0
-$2K 6323
2015
Q3
Hold
0
6592